Blogs & Articles

LATEST ARTICLE

China issues 2021 national reimbursement drugs list, three key trends…

By GPI Global Pricing Innovations | 23 December 2021
China published its annual update to the national reimbursement drug list (NRDL) on 3rd December, which will be implemented from 1st January 2022. A total of seventy-four drugs entered the NRDL and eleven were removed. Sixty-seven (91%) of the drugs that were added are novel therapies reimbursed for the first time in China. Price negotiation with the…
Read more
All
  • All
  • Articles
  • Blogs
  • Research
China Reimbursement

China issues 2021 national reimbursement drugs list, three key trends…

23 December 2021
Build-Back-Better-US-small

Build Back Better could set new precedent for US drug pricing controls

3 December 2021
GPI-Pulse-10-steps

10 steps for a successful market access strategy

20 September 2021
GPI horizon

GPI horizon, the price forecasting methodology that is transforming market access strategy

27 August 2021
drug pricing revolution

“It’s Time For A Prescription Drug Pricing Revolution…”

6 August 2021
Consulting industry disruption

GPI Horizon represents the major disruption happening in the consulting industry

27 May 2021
GPI horizon

Early Pricing and Market Access Forecasting for Orphan Assets

20 May 2021
Agile

GPI’s Agile approach to project management helps to ensure project success.

5 May 2021